Related Experiment Videos
Generation of amyloid beta protein from its precursor is sequence specific
M Citron1, D B Teplow, D J Selkoe
1Department of Neurology, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts 02115.
Neuron
|March 1, 1995
Summary
Alzheimer's disease involves amyloid beta (A beta) protein buildup. This study reveals beta-secretase enzyme recognition sites on the beta-amyloid precursor protein (beta APP), crucial for A beta production and Alzheimer's disease research.
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- Cerebral amyloid beta (A beta) protein deposition is a key early feature of Alzheimer's disease.
- Understanding the enzymes that produce A beta is critical for developing therapeutic strategies.
Purpose of the Study:
- To analyze the substrate requirements of beta-secretases that cleave beta-amyloid precursor protein (beta APP) in human cells.
- To identify the specific recognition sequences and cellular localization involved in A beta production.
Main Methods:
- Analysis of beta-secretase cleavage sites on membrane-bound beta APP in intact human cells.
- Site-directed mutagenesis to investigate the effects of specific amino acid substitutions and deletions on A beta production.
Main Results:
- Beta-secretase cleavage requires a membrane-bound substrate and has a minimum recognition region (Val-594 to Ala-598).
- Most substitutions in this region decrease or abolish A beta production, except for the Swedish familial Alzheimer's disease mutation (K595N/M596L), which increases it.
- Cleavage of the Swedish mutant occurs in a different cellular compartment than wild-type beta APP, as evidenced by tolerance to cytoplasmic tail deletions.
Conclusions:
- The findings provide critical insights into the substrate specificity and cellular processing of beta APP by beta-secretases.
- This knowledge is vital for developing targeted assays and inhibitors for beta-secretase activity to combat Alzheimer's disease.